7 leading Contract Research Organization Services (CROs) provides Clinical Research Solution

Posted by : Admin 20-Jul-2022   859   0  


As per Business Intelligence Insights (BII) study, the Global Contract Research Organization Services (CROs) Market attained revenue growth of 63.4 billion in 2021 and it is projected to reach around USD 155.9 billion by 2030, growing at a 11.90% CAGR. Click here_to request a sample report containing detailed insights into market trends expected in the coming years.

A "contract research organisation" is a business that offers clinical management services to pharmaceutical, biotechnology, and medical device companies. Sponsors, manufacturers, ethical committees, competent authorities, foundations, researchers, centres, and legal departments are all involved in the complexities of clinical trial management. Furthermore, adhering to good clinical practise and harmonisation guidelines is critical to the study's quality. The majority of CRO revenue is generated by the R&D budgets of pharmaceutical, biotechnology, medical device, government, and other medical research firms. Similarly, CRO revenue will grow as a result of increased R&D spending and the expansion of pharmaceutical R&D outsourcing.

CRO services are becoming more popular as the demand for time-efficient and cost-effective drug development with deep therapeutic knowledge grows. In many cases, outsourcing R&D operations allows companies to reduce internal costs by leveraging the capacity, scale, and expertise of CROs. As a result, significant outsourced penetration is expected in the clinical development and post-approval stages. Certain early-stage operations, such as safety evaluation and regulatory-related services, are also fuelling outsourcing trends and hastening market expansion. The organisations collaborate with other companies to create novel items that aid in clinical trials. Obesity and diabetes are becoming more common as a result of their widespread prevalence and earlier onset, accounting for more than half of all chronic disease deaths. Chronic illness affects people all over the world, not just in wealthy nations. Contrary to popular belief, developing countries are increasingly plagued by chronic disease-related public health issues.

 IQVIA Inc.

IQVIA, originally Quintiles and IMS Health, Inc., is an American multinational corporation that provides services to the clinical research and health information technology industries, founded in 1982. IQVIA is a provider of biopharmaceutical development and commercial outsourcing services. As of August 2021, it had a market worth of $49 billion and a network of more than 88,000 employees across more than 100 nations. Ari Bousbib is the CEO of IQVIA. According to reports, one of the largest contract research organisations in the world as of 2017 was IQVIA.

Syneos Health Inc. (US)

Syneos Health, headquartered in Morrisville, North Carolina, is a NASDAQ-listed American multinational contract research organisation, established in 1984. This Company specialises on supporting businesses with advanced clinical studies. Syneos Health's current CEO is Michelle Keefe. The Biopharmaceutical Acceleration Model(BMA) is a corporation that only Syneos Health operates in the biopharmaceutical services sector. Across their clinical and commercial capabilities, BAM is an end-to-end concept that is driven by each and every Employee. The number of employees working in the company is around 28,000 (as 2022).

charles river

Charles River Laboratories International, Inc., is a U.S.-based pharmaceutical company that specialises in preclinical and clinical laboratories, research models and support services for drug discovery and development. Charles River was founded in 1947. Its Service Areas are Basic research, discovery, safety and efficacy, clinical support, and manufacturing. Around 20,000+ employees working in the company. Revenue of Charles River Laboratories $3.5 billion in FY2021. James C. Foster is The CEO of Charles River.

Parexel International Corporation (US)

Parexel International Corporation (US) is American company established in  1982 by Josef von Rickenbach and organic chemist Anne B. Sayigh . Parexel offers biopharmaceutical services, clinical development skills and integrated consulting knowledge required to speed up and more effectively streamline development at every stage. Parexel is one of the top worldwide clinical research companies (CROs). Jamie Macdonald is Chief Executive Officer of Parexel. The company has approximately 18,900 employees.

SGS SA

SGS SA formerly General Society of Surveillance is Swiss multinational corporation with its headquarters in Geneva, founded in 1878. SGS company offer the most comprehensive range of inspection, testing, certification, and advisory services anywhere in the world. In March 2015, Frankie Ng was appointed Chief Executive Officer of SGS. Worldwide there are 96,000 employees (as 2021) in the Company.

Pharmaron Beijing Co., Ltd. (China)

Pharmaron is a leading provider of R&D services to the life sciences industry, founded in 2004. Boliang Lou is the Co-founder and CEO of company. Pharmaron Beijing Co., Ltd. offers testing services for medical devices and conducts clinical research in addition to engaging in the discovery, development, and production of small molecule pharmaceuticals, cell treatments, and gene therapies. Pharmaron has a proven track record of providing R&D solutions to its partners in North America, Europe, Japan, and China. Pharmaron has over 17,000 workers with operations in China, the U.S., and the U.K.

ICON

ICON plc is American Irish-based clinical research organisation, founded in Dublin, Ireland in 1990 by John Climax and Ronan Lambe. Icon offers consulting, clinical development, and commercialization services to the pharmaceutical industry. Across 46 countries, ICON had 38,000 employees(as November 2021). Through a number of prestigious industry awards, ICON has been acknowledged as one of the top Contract Research Organizations in the world. In March 2017, Dr. Steve Cutler was appointed CEO of ICON plc.

 

 


 



Leave a comment

Your email address will not be published. Required fields are marked *

Copyright © Business Intelligence Insights.